Atlas Trials

LANdiolol MIcrocirculatory Effects During Septic chOc (MILANOS)

Clinical trial NCT04931225 · RECRUITING

Trial details

NCT number
NCT04931225
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Septic Shock
Start date
2022-07-18
Primary completion
2026-07-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.